Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECALLANTIDE vs EDOXABAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ECALLANTIDE vs EDOXABAN: Safety Overview

Metric ECALLANTIDE EDOXABAN
Total FAERS Reports 1,206 8,334
Deaths Reported 23 992
Death Rate 1.9% 11.9%
Hospitalizations 499 4,729
Average Patient Age 42.9 yrs 77.2 yrs
% Female Patients 84.1% 46.5%
FDA Approval Date N/A Jan 8, 2015
Manufacturer Takeda Pharmaceuticals America, Inc. Daiichi Sankyo Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription